A detailed history of Federated Hermes, Inc. transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 1,947,100 shares of AMPH stock, worth $76.2 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
1,947,100
Previous 1,944,800 0.12%
Holding current value
$76.2 Million
Previous $77.8 Million 21.47%
% of portfolio
0.22%
Previous 0.19%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$36.99 - $50.09 $85,077 - $115,207
2,300 Added 0.12%
1,947,100 $94.5 Million
Q2 2024

Aug 08, 2024

SELL
$38.65 - $43.48 $5.11 Million - $5.75 Million
-132,301 Reduced 6.37%
1,944,800 $77.8 Million
Q1 2024

May 14, 2024

SELL
$42.85 - $63.45 $51.2 Million - $75.9 Million
-1,195,660 Reduced 36.53%
2,077,101 $91.2 Million
Q4 2023

Jan 31, 2024

SELL
$44.49 - $62.93 $7.54 Million - $10.7 Million
-169,473 Reduced 4.92%
3,272,761 $202 Million
Q3 2023

Nov 13, 2023

BUY
$45.51 - $65.0 $605,465 - $864,760
13,304 Added 0.39%
3,442,234 $158 Million
Q2 2023

Aug 14, 2023

BUY
$35.77 - $58.38 $1.51 Million - $2.47 Million
42,317 Added 1.25%
3,428,930 $197 Million
Q1 2023

May 08, 2023

BUY
$27.99 - $37.92 $2.87 Million - $3.88 Million
102,396 Added 3.12%
3,386,613 $127 Million
Q4 2022

Feb 13, 2023

BUY
$27.93 - $31.27 $531,731 - $595,318
19,038 Added 0.58%
3,284,217 $92 Million
Q3 2022

Nov 14, 2022

SELL
$27.56 - $37.75 $490,237 - $671,497
-17,788 Reduced 0.54%
3,265,179 $91.8 Million
Q2 2022

Aug 15, 2022

SELL
$29.79 - $42.29 $6.09 Million - $8.65 Million
-204,463 Reduced 5.86%
3,282,967 $114 Million
Q1 2022

May 13, 2022

BUY
$22.96 - $36.45 $530,261 - $841,812
23,095 Added 0.67%
3,487,430 $125 Million
Q4 2021

Feb 14, 2022

SELL
$18.14 - $23.29 $12,516 - $16,070
-690 Reduced 0.02%
3,464,335 $80.7 Million
Q3 2021

Nov 15, 2021

BUY
$17.83 - $21.49 $2.2 Million - $2.65 Million
123,524 Added 3.7%
3,465,025 $65.9 Million
Q2 2021

Aug 16, 2021

SELL
$17.11 - $20.92 $1.71 Million - $2.09 Million
-99,866 Reduced 2.9%
3,341,501 $67.4 Million
Q1 2021

May 13, 2021

BUY
$17.21 - $20.65 $3.71 Million - $4.45 Million
215,484 Added 6.68%
3,441,367 $63 Million
Q4 2020

Feb 12, 2021

BUY
$17.76 - $21.24 $8.62 Million - $10.3 Million
485,525 Added 17.72%
3,225,883 $64.9 Million
Q3 2020

Nov 12, 2020

BUY
$17.99 - $22.22 $2.52 Million - $3.12 Million
140,251 Added 5.39%
2,740,358 $51.4 Million
Q2 2020

Aug 13, 2020

SELL
$14.25 - $22.46 $185 - $291
-13 Reduced -0.0%
2,600,107 $58.4 Million
Q1 2020

May 13, 2020

BUY
$12.66 - $20.08 $10.8 Million - $17.1 Million
852,213 Added 48.76%
2,600,120 $38.6 Million
Q4 2019

Feb 14, 2020

SELL
$17.07 - $20.64 $238 - $288
-14 Reduced -0.0%
1,747,907 $33.7 Million
Q3 2019

Nov 14, 2019

BUY
$19.12 - $22.62 $2.29 Million - $2.71 Million
120,018 Added 7.37%
1,747,921 $34.7 Million
Q2 2019

Aug 14, 2019

BUY
$18.92 - $22.96 $2.93 Million - $3.56 Million
154,972 Added 10.52%
1,627,903 $34.4 Million
Q1 2019

May 10, 2019

BUY
$19.46 - $25.28 $2.29 Million - $2.97 Million
117,480 Added 8.67%
1,472,931 $30.1 Million
Q4 2018

Feb 13, 2019

BUY
$17.72 - $22.51 $1.4 Million - $1.78 Million
78,943 Added 6.18%
1,355,451 $27 Million
Q3 2018

Nov 13, 2018

SELL
$15.39 - $19.38 $677 - $852
-44 Reduced -0.0%
1,276,508 $24.6 Million
Q2 2018

Aug 10, 2018

BUY
$14.63 - $19.6 $3.32 Million - $4.45 Million
227,142 Added 21.64%
1,276,552 $19.5 Million
Q1 2018

May 09, 2018

BUY
$17.23 - $20.35 $258 - $305
15 Added 0.0%
1,049,410 $19.7 Million
Q4 2017

Feb 14, 2018

SELL
$17.76 - $19.75 $124 - $138
-7 Reduced -0.0%
1,049,395 $0
Q3 2017

Nov 13, 2017

BUY
$14.73 - $17.99 $15.5 Million - $18.9 Million
1,049,402
1,049,402 $18.8 Million

Others Institutions Holding AMPH

About Amphastar Pharmaceuticals, Inc.


  • Ticker AMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,015,200
  • Market Cap $1.92B
  • Description
  • Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...
More about AMPH
Track This Portfolio

Track Federated Hermes, Inc. Portfolio

Follow Federated Hermes, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.